{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-014816","form_type":"8-K","ticker":null,"cik":"0000849636","company_name":"RespireRx Pharmaceuticals Inc.","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.139137+00:00","generated_at":"2026-06-03T22:39:17.332955+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"RespireRx enters $100K demand note with director Nasiek; warrant for 33.3M shares","bullets":["$100,000 demand promissory note issued to Dariusz Nasiek and Sara Nasiek JTTEN; 10% interest payable on demand.","Warrant to purchase 33,333,333 shares of common stock at $0.0015/share, exercisable for 5 years.","Proceeds used for working capital, R&D, and general corporate purposes.","Dariusz Nasiek is a Board member; transaction is a related-party arrangement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-014816","json":"https://secwatch.observer/filing/0001493152-24-014816.json","markdown":"https://secwatch.observer/filing/0001493152-24-014816.md","text":"https://secwatch.observer/filing/0001493152-24-014816.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849636/000149315224014816/0001493152-24-014816-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849636/000149315224014816/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:39:17.332955+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c4fd1540305485b5ffe3e40b040769e1ef2bafc3","claim":"RespireRx Pharmaceuticals Inc. entered into Purchase Agreement with Dariusz Nasiek and Sara Nasiek, JTTEN valued at $100,000.00 (effective 2024-04-10).","evidence_excerpt":"On April 10, 2024, the RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”) entered into a Demand Promissory Note and Warrant Agreement (“Purchase Agreement”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/849636/000149315224014816/0001493152-24-014816-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Dariusz Nasiek and Sara Nasiek, JTTEN"},{"label":"Value","value":"$100,000.00"},{"label":"Effective","value":"2024-04-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}